IS7385A - Fjölgervingar klópídógrelhýdróklóríðs og notkun þeirra sem andsegaefnasambanda - Google Patents

Fjölgervingar klópídógrelhýdróklóríðs og notkun þeirra sem andsegaefnasambanda

Info

Publication number
IS7385A
IS7385A IS7385A IS7385A IS7385A IS 7385 A IS7385 A IS 7385A IS 7385 A IS7385 A IS 7385A IS 7385 A IS7385 A IS 7385A IS 7385 A IS7385 A IS 7385A
Authority
IS
Iceland
Prior art keywords
antioxidants
clopidogrel hydrochloride
synthetics
multiple synthetics
clopidogrel
Prior art date
Application number
IS7385A
Other languages
English (en)
Inventor
Kotay Nagy Péter
Barkoczy Jozsef
Simig Gyula
Szent Kir βllyi Zsuzsa
βs Gregor Tam
Farkas Béla
Vereczkey Né Don βth Györgyi
βlm βn Nagy K
βné Körtvélyessy Gyul
Original Assignee
Egis Gyogyszergyir Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyir Rt. filed Critical Egis Gyogyszergyir Rt.
Publication of IS7385A publication Critical patent/IS7385A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
IS7385A 2002-02-06 2004-08-05 Fjölgervingar klópídógrelhýdróklóríðs og notkun þeirra sem andsegaefnasambanda IS7385A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0200438A HUP0200438A3 (en) 2002-02-06 2002-02-06 Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
PCT/HU2002/000157 WO2003066637A1 (en) 2002-02-06 2002-12-20 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds

Publications (1)

Publication Number Publication Date
IS7385A true IS7385A (is) 2004-08-05

Family

ID=89980128

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7385A IS7385A (is) 2002-02-06 2004-08-05 Fjölgervingar klópídógrelhýdróklóríðs og notkun þeirra sem andsegaefnasambanda

Country Status (15)

Country Link
US (1) US20050113406A1 (is)
EP (1) EP1474427A1 (is)
JP (1) JP2005522441A (is)
KR (1) KR20040079987A (is)
AU (1) AU2002353251A1 (is)
BG (1) BG108868A (is)
CZ (1) CZ2004901A3 (is)
EA (1) EA007119B1 (is)
HR (1) HRP20040741A2 (is)
HU (1) HUP0200438A3 (is)
IS (1) IS7385A (is)
PL (1) PL370038A1 (is)
SK (1) SK3362004A3 (is)
WO (1) WO2003066637A1 (is)
YU (1) YU69604A (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1713812A1 (en) * 2004-01-13 2006-10-25 Zentiva, a.s. New crystalline forms of clopidogrel hydrobromide and methods of their preparation
WO2005104663A2 (en) * 2004-03-05 2005-11-10 Ipca Laboratories Limited Industrial process for preparation of clopidogrel hydrogen sulphate
RU2328501C1 (ru) * 2004-04-09 2008-07-10 Ханми Фарм. Ко., ЛТД Кристаллический клопидогрель нафталинсульфонат или его гидрат, способ его получения и содержащая его фармацевтическая композиция
CN1997647A (zh) * 2004-04-20 2007-07-11 赛诺菲-安万特 氯吡格雷盐及其多晶型物
CA2562507A1 (en) * 2004-04-20 2005-11-03 Sanofi-Aventis Polymorphic forms of methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate hydrobromide, clopidrogel hydrobromide
WO2005117866A1 (en) * 2004-06-01 2005-12-15 Ivax Pharmaceuticals S.R.O. Amorphous clopidogrel hydrochloride and its antithrombotic use
EP1674468A1 (en) * 2004-12-21 2006-06-28 Ratiopharm GmbH Polymorphs of clopidogrel hydrobromide
EP1693375A1 (en) * 2005-02-21 2006-08-23 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing clopidrogel hydrogen sulfate of form I
WO2007029096A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Novel polymorphic forms of clopidogrel hydrochloride
WO2007029080A1 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Preparation of form i of clopidogrel hydrochloride
KR20070066518A (ko) * 2005-12-22 2007-06-27 에스케이케미칼주식회사 고체상 반응을 이용한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR101235117B1 (ko) * 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR100742134B1 (ko) * 2006-02-07 2007-07-24 경동제약 주식회사 결정성Ｓ-(+)-메틸-2-(2-클로로페닐)-2-(6,7-디히드로티에노[3,2-ｃ]피리딘-5(4Ｈ)-일)아세테이트·캄실레이트를 포함하는약학적 조성물
WO2008004249A2 (en) * 2006-07-04 2008-01-10 Msn Laboratories Limited An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
US20100062066A1 (en) * 2006-11-14 2010-03-11 Acusphere, Inc Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
EP1970054A3 (en) 2007-03-14 2009-06-03 Ranbaxy Laboratories Limited Clopidogrel tablets
US8343995B2 (en) 2007-04-27 2013-01-01 Cydex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
US7985859B2 (en) * 2007-05-30 2011-07-26 Wockhardt Ltd. Processes for the preparation of clopidogrel
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
KR20190071006A (ko) 2009-05-13 2019-06-21 사이덱스 파마슈티칼스, 인크. 프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법
CN102120745B (zh) * 2011-01-31 2013-04-10 天津红日药业股份有限公司 一种盐酸氯吡格雷的晶型ⅰ及其制备方法和用途
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
CN102367257B (zh) * 2011-11-21 2014-05-07 天津红日药业股份有限公司 氯吡格雷盐酸盐的单晶晶型，它们的制备及应用
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5189170A (en) * 1989-09-29 1993-02-23 Sanofi Process for the preparation of phenylacetic derivatives of thieno-pyridines
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
HU225504B1 (en) * 1997-05-13 2007-01-29 Sanofi Aventis Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides

Also Published As

Publication number Publication date
AU2002353251A1 (en) 2003-09-02
KR20040079987A (ko) 2004-09-16
EP1474427A1 (en) 2004-11-10
HU0200438D0 (en) 2002-04-29
EA200401025A1 (ru) 2004-12-30
WO2003066637A1 (en) 2003-08-14
US20050113406A1 (en) 2005-05-26
CZ2004901A3 (cs) 2005-02-16
JP2005522441A (ja) 2005-07-28
HRP20040741A2 (en) 2004-12-31
HUP0200438A3 (en) 2003-10-28
HUP0200438A2 (hu) 2003-09-29
YU69604A (sh) 2006-08-17
BG108868A (en) 2005-09-30
EA007119B1 (ru) 2006-06-30
PL370038A1 (en) 2005-05-16
SK3362004A3 (sk) 2005-03-04

Similar Documents

Publication Publication Date Title
IS7385A (is) Fjölgervingar klópídógrelhýdróklóríðs og notkun þeirra sem andsegaefnasambanda
HK1087699A1 (en) Gyrase inhibitors and uses thereof
HK1067945A1 (en) Substituted benzazoles and use thereof as raf kinase inhibitors
IS7434A (is) N-amínóasetýl-pýrrólídín-2-karbónítríl og notkun þeirra sem DDP-IV tálma
IS2529B (is) Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
IS2914B (is) Kínólín afleiður og notkun þeirra sem tálma sveppagerla
AU2003303128A8 (en) Inhibitors and methods of use thereof
EG27049A (en) P38 inhibitors and methods of use thereof
PL375447A1 (en) Protein kinase inhibitors and uses thereof
IL172471A0 (en) Gsk-3 inhibitors and uses thereof
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
IL187620A0 (en) 17??-hsd1 and sts inhibitors
HK1083096A1 (en) Casr antagonist casr
ZA200509700B (en) Caspase inhibitors and uses thereof
HK1100927A1 (en) Substituted quinolines and their use as mycobacterial inhibitors
FI20020001A0 (fi) Palonsammutusmenetelmõ ja -laitteisto
AU2003232848A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
AU2003264261A8 (en) Isoprostanes as markers of psychological stress in humans
EP1682115A4 (en) HIF-1 HEMMER AND APPLICATION METHOD THEREFOR
AU2003251513A8 (en) Rsk inhibitors and therapeutic uses thereof
EP1545287A4 (en) VASOREGULATORY COMPOUNDS AND METHODS RELATING TO THEIR USE
GB0206415D0 (en) Deracemisation of amines
GB0411145D0 (en) Protease inhibitors and their therapeutic applications
SI1677779T1 (sl) Kombinacija iz antagonista receptorja tp in klopidogrela